ZYUS Life Sciences Corporation (CVE:ZYU – Free Report) – Equities researchers at Stifel Canada issued their FY2024 EPS estimates for ZYUS Life Sciences in a research report issued on Wednesday, March 5th. Stifel Canada analyst J. Keywood forecasts that the company will post earnings of ($0.24) per share for the year. Stifel Canada also issued estimates for ZYUS Life Sciences’ Q4 2024 earnings at ($0.07) EPS.
ZYUS Life Sciences Stock Performance
Featured Stories
- Five stocks we like better than ZYUS Life Sciences
- Want to Profit on the Downtrend? Downtrends, Explained.
- NVIDIA Stock Remains Stunningly Undervalued—Here’s Why
- Pros And Cons Of Monthly Dividend Stocks
- Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy
- High Dividend REITs: Are They an Ideal Way to Diversify?
- U.S. Stocks Sink, Foreign Markets Soar: 3 ETFs to Ride the Wave
Receive News & Ratings for ZYUS Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZYUS Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
